EUGENE L ELMORE

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Short tandem repeat profiling: part of an overall strategy for reducing the frequency of cell misidentification
    Raymond W Nims
    RMC Pharmaceutical Solutions Inc, 2150 Miller Drive, Longmont, CO 80501, USA
    In Vitro Cell Dev Biol Anim 46:811-9. 2010
  2. ncbi Recommendation of short tandem repeat profiling for authenticating human cell lines, stem cells, and tissues
    Rita Barallon
    LGC, Queens Road, Teddington, Middlesex TW11 0LY, UK
    In Vitro Cell Dev Biol Anim 46:727-32. 2010
  3. ncbi Comparative tissue-specific toxicities of 20 cancer preventive agents using cultured cells from 8 different normal human epithelia
    E Elmore
    Department of Radiation Oncology, Medical Sciences I, University of California Irvine, Irvine, CA 92697, USA
    In Vitr Mol Toxicol 14:191-207. 2001
  4. ncbi The human epithelial cell cytotoxicity assay for determining tissue specific toxicity: method modifications
    Eugene Elmore
    Department of Radiation Oncology and Chao Family Comprehensive Cancer Center, University of California, Medical Sciences I, B149, Irvine, CA 92697, USA
    Methods Cell Sci 24:145-53. 2002
  5. ncbi Correlation of in vitro chemopreventive efficacy data from the human epidermal cell assay with animal efficacy data and clinical trial plasma levels
    Eugene Elmore
    Department of Radiation Oncology, University of California Irvine, Irvine, CA 92697, USA
    J Cell Biochem 95:571-88. 2005
  6. ncbi Development and characteristics of a human cell assay for screening agents for melanoma prevention
    Eugene Elmore
    Department of Radiation Oncology, University of California, Irvine, California 92697 2695, USA
    Melanoma Res 17:42-50. 2007

Research Grants

  1. In Vitro Cancer Prevention Biomarker Development
    Eugene Elmore; Fiscal Year: 2004

Collaborators

  • Vernon E Steele
  • Margaret C Kline
  • ROLAND M NARDONE
  • Frank Louis Meyskens
  • Raymond W Nims
  • Rita Barallon
  • Paul J Price
  • Roderick A F MacLeod
  • Liz Kerrigan
  • Douglas R Storts
  • Yvonne A Reid
  • Wilhelm G Dirks
  • Arihiro Kohara
  • Amanda Capes-Davis
  • Steven R Bauer
  • Christine Alston-Roberts
  • Karin Cottrill
  • Jaiprakash Shewale
  • Manohar Furtado
  • John Butler
  • Anton F Steuer
  • Greg Sykes
  • Gregory Sykes
  • Mark Nardone
  • Pranvera Ikonomi
  • Jim Thomson
  • Georgyi V Los
  • Zenobia Taraporewala
  • John R W Masters

Detail Information

Publications6

  1. ncbi Short tandem repeat profiling: part of an overall strategy for reducing the frequency of cell misidentification
    Raymond W Nims
    RMC Pharmaceutical Solutions Inc, 2150 Miller Drive, Longmont, CO 80501, USA
    In Vitro Cell Dev Biol Anim 46:811-9. 2010
    ..Karyotyping may also be needed as a supporting tool during establishment of an STR database. Finally, good cell culture practices must always remain a major component of any effort to reduce the frequency of cell misidentification...
  2. ncbi Recommendation of short tandem repeat profiling for authenticating human cell lines, stem cells, and tissues
    Rita Barallon
    LGC, Queens Road, Teddington, Middlesex TW11 0LY, UK
    In Vitro Cell Dev Biol Anim 46:727-32. 2010
    ..The consensus standard is anticipated to be adopted by granting agencies and scientific journals as appropriate methodology for authenticating human cell lines, stem cells, and tissues...
  3. ncbi Comparative tissue-specific toxicities of 20 cancer preventive agents using cultured cells from 8 different normal human epithelia
    E Elmore
    Department of Radiation Oncology, Medical Sciences I, University of California Irvine, Irvine, CA 92697, USA
    In Vitr Mol Toxicol 14:191-207. 2001
    ..The HECC Assay is effective in identifying tissue-specific toxicity for chemopreventive agents and may help to identify potential toxicity problems in phase I human clinical trials...
  4. ncbi The human epithelial cell cytotoxicity assay for determining tissue specific toxicity: method modifications
    Eugene Elmore
    Department of Radiation Oncology and Chao Family Comprehensive Cancer Center, University of California, Medical Sciences I, B149, Irvine, CA 92697, USA
    Methods Cell Sci 24:145-53. 2002
    ....
  5. ncbi Correlation of in vitro chemopreventive efficacy data from the human epidermal cell assay with animal efficacy data and clinical trial plasma levels
    Eugene Elmore
    Department of Radiation Oncology, University of California Irvine, Irvine, CA 92697, USA
    J Cell Biochem 95:571-88. 2005
    ..Thus, the HEC assay has an excellent predictive potential for animal efficacy and is responsive at clinically achievable concentrations...
  6. ncbi Development and characteristics of a human cell assay for screening agents for melanoma prevention
    Eugene Elmore
    Department of Radiation Oncology, University of California, Irvine, California 92697 2695, USA
    Melanoma Res 17:42-50. 2007
    ....

Research Grants1

  1. In Vitro Cancer Prevention Biomarker Development
    Eugene Elmore; Fiscal Year: 2004
    ..Using cluster analysis, we will determine the global gene expression changes induced by each agent. The strength of the proposed approach lies in the high quality data that has already determined from the HEC Assay. ..